Nurse Practitioner, Family · Charlotte, NC
NPI
1124359021
Since 2010
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
4525 Cameron Valley Parkway
Charlotte, NC, 28211
Phone (704) 302-8310
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,273
45 services
Medicare patients, 2024
18
Average age 62
Drug cost, 2024
$2.0M
2,260 prescriptions
Company payments, 2025
$1,565
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jean Thibault was code 99214 (office e&m - established), 41 times for 18 patients. In total Jean Thibault billed 45 services in 3 codes, and Medicare paid $2,273.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 41 | 18 | $51.12 | $2,096 |
By year: 2022 $1,936 for 69 services; 2024 $2,273 for 45 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 31 | 23 | $2.99 | $92.67 |
Medicare prescription drug claims, 2024
In 2024, the drug Jean Thibault prescribed most often to Medicare patients was Rosuvastatin Calcium, with 115 prescriptions and refills. In total Jean Thibault wrote 2,260 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 115 | 167 | 16 | $956 |
| Tivicay Dolutegravir Sodium | 114 | 114 | 11 | $261K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 112 | 112 | 13 | $443K |
| Descovy Emtricitabine/Tenofov Alafenam | 77 | 77 | Under 11 | $171K |
| Dovato Dolutegravir Sodium/Lamivudine | 72 | 72 | Under 11 | $221K |
| Lisinopril Generic | 61 | 92 | Under 11 | $168 |
| Amlodipine Besylate Generic | 60 | 64 | Under 11 | $194 |
| Hydroxyzine Hcl Generic | 56 | 64 | Under 11 | $1,138 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 55 | 55 | Under 11 | $192K |
| Atorvastatin Calcium Generic | 46 | 84 | Under 11 | $204 |
| Omeprazole Generic | 45 | 51 | Under 11 | $407 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 42 | 42 | Under 11 | $201K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 41 | 41 | Under 11 | $153K |
| Montelukast Sodium Generic | 41 | 47 | Under 11 | $207 |
| Losartan Potassium Generic | 40 | 50 | Under 11 | $159 |
Brand drugs: 706 claims; generic drugs: 1,510 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jean Thibault $1,565 ($1,565 in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $539.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.